{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:50:18Z","timestamp":1782337818343,"version":"3.54.5"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Lambert Initiative for Cannabinoid Therapeutics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sports Med - Open"],"DOI":"10.1186\/s40798-025-00895-w","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T12:46:30Z","timestamp":1755780390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Acute Effects of Cannabidiol on Physiological and Subjective Responses to Endurance Exercise: A Dose-Ranging Randomised Controlled Crossover Trial"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-2342","authenticated-orcid":false,"given":"Ayshe","family":"Sahinovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namson S.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Sabag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Desbrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain S.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7783-5220","authenticated-orcid":false,"given":"Danielle","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"12","key":"895_CR1","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1039\/C6NP00074F","volume":"33","author":"LO Hanus","year":"2016","unstructured":"Hanus LO, et al. Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016;33(12):1357\u201392.","journal-title":"Nat Prod Rep"},{"issue":"5","key":"895_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2749","volume":"35","author":"D McCartney","year":"2020","unstructured":"McCartney D, et al. The effect of cannabidiol on simulated car driving performance: a randomised, double-blind, placebo-controlled, crossover, dose-ranging clinical trial protocol. Hum Psychopharmacol Clin Exp. 2020;35(5): e2749.","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"7","key":"895_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.4841","volume":"1","author":"TR Spindle","year":"2018","unstructured":"Spindle TR, et al. Acute effects of smoked and vaporized cannabis in healthy adults who infrequently use cannabis: a crossover trial. JAMA Netw Open. 2018;1(7): e184841.","journal-title":"JAMA Netw Open"},{"key":"895_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107937","volume":"211","author":"TR Spindle","year":"2020","unstructured":"Spindle TR, et al. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users. Drug Alcohol Depend. 2020;211: 107937.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"895_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","volume":"238","author":"SC Britch","year":"2021","unstructured":"Britch SC, Babalonis S, Walsh SL. Cannabidiol: pharmacology and therapeutic targets. Psychopharmacology. 2021;238(1):9\u201328.","journal-title":"Psychopharmacology"},{"issue":"3","key":"895_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/epi.14670","volume":"60","author":"E Thiele","year":"2019","unstructured":"Thiele E, et al. Cannabidiol in patients with Lennox-Gastaut syndrome: interim analysis of an open-label extension study. Epilepsia. 2019;60(3):419\u201328.","journal-title":"Epilepsia"},{"issue":"20","key":"895_CR7","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","volume":"378","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, et al. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med. 2018;378(20):1888\u201397.","journal-title":"N Engl J Med"},{"issue":"21","key":"895_CR8","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky O, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017;376(21):2011\u201320.","journal-title":"N Engl J Med"},{"key":"895_CR9","unstructured":"U.S. Food and Drug Administration Center for Drug Evaluation and Research. Epidiolex NDA 210365 Approval Letter. June 25, 2018 [cited 2021 30th March]; Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/210365Orig1s000Approv.pdf."},{"key":"895_CR10","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.21m14130","volume":"83","author":"M Berger","year":"2022","unstructured":"Berger M, et al. Cannabidiol for treatment-resistant anxiety disorders in young people: an open-label trial. J Clin Psychiatry. 2022;83: 21m14130. https:\/\/doi.org\/10.4088\/jcp.21m14130.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"895_CR11","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/npp.2011.6","volume":"36","author":"MM Bergamaschi","year":"2011","unstructured":"Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology. 2011;36(6):1219\u201326.","journal-title":"Neuropsychopharmacology"},{"key":"895_CR12","doi-asserted-by":"crossref","unstructured":"Masataka N. Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders. Front Psychol. 2019;10.","DOI":"10.3389\/fpsyg.2019.02466"},{"issue":"1","key":"895_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40798-020-00251-0","volume":"6","author":"D McCartney","year":"2020","unstructured":"McCartney D, et al. Cannabidiol and sports performance: a narrative review of relevant evidence and recommendations for future research. Sports Med Open. 2020;6(1):27.","journal-title":"Sports Med Open"},{"key":"895_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01365","author":"SA Millar","year":"2018","unstructured":"Millar SA, et al. A systematic review on the pharmacokinetics of cannabidiol in humans. Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/fphar.2018.01365.","journal-title":"Front Pharmacol"},{"issue":"10","key":"895_CR15","doi-asserted-by":"publisher","first-page":"e1913853","DOI":"10.1001\/jamanetworkopen.2019.13853","volume":"2","author":"EC Leas","year":"2019","unstructured":"Leas EC, et al. Trends in internet searches for cannabidiol (CBD) in the United States. JAMA Netw Open. 2019;2(10):e1913853.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"895_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cts.13425","volume":"16","author":"JC Arnold","year":"2023","unstructured":"Arnold JC, et al. The safety and efficacy of low oral doses of cannabidiol: an evaluation of the evidence. Clin Transl Sci. 2023;16(1):10\u201330.","journal-title":"Clin Transl Sci"},{"issue":"6","key":"895_CR17","doi-asserted-by":"publisher","first-page":"e0218998","DOI":"10.1371\/journal.pone.0218998","volume":"14","author":"JS Zeiger","year":"2019","unstructured":"Zeiger JS, et al. Cannabis use in active athletes: behaviors related to subjective effects. PLoS ONE. 2019;14(6):e0218998\u2013e0218998.","journal-title":"PLoS ONE"},{"issue":"5","key":"895_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1123\/ijsnem.2020-0151","volume":"30","author":"AM Kasper","year":"2020","unstructured":"Kasper AM, et al. High prevalence of cannabidiol use within male professional rugby union and league players: a quest for pain relief and enhanced recovery. Int J Sport Nutr Exerc Metab. 2020;30(5):315\u201322.","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"895_CR19","unstructured":"World Anti Doping Agency. Summary of Major Modifications and Explanatory Notes. 2018 30 March 2021]; Available from: https:\/\/www.wada-ama.org\/sites\/default\/files\/prohibited_list_2018_summary_of_modifications_en.pdf."},{"key":"895_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102935","volume":"85","author":"IS McGregor","year":"2020","unstructured":"McGregor IS, et al. Access to cannabidiol without a prescription: a cross-country comparison and analysis. Int J Drug Policy. 2020;85: 102935.","journal-title":"Int J Drug Policy"},{"key":"895_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10061133","author":"BW Crossland","year":"2022","unstructured":"Crossland BW, et al. Acute supplementation with cannabidiol does not attenuate inflammation or improve measures of performance following strenuous exercise. Healthcare. 2022. https:\/\/doi.org\/10.3390\/healthcare10061133.","journal-title":"Healthcare"},{"issue":"7","key":"895_CR22","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1249\/MSS.0000000000002606","volume":"53","author":"KC Cochrane-Snyman","year":"2021","unstructured":"Cochrane-Snyman KC, et al. The effects of cannabidiol oil on noninvasive measures of muscle damage in men. Med Sci Sports Exerc. 2021;53(7):1460\u201372.","journal-title":"Med Sci Sports Exerc"},{"key":"895_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093028","author":"E Isenmann","year":"2021","unstructured":"Isenmann E, et al. Effects of cannabidiol supplementation on skeletal muscle regeneration after intensive resistance training. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13093028.","journal-title":"Nutrients"},{"key":"895_CR24","first-page":"89","volume":"7","author":"AA Hatchett","year":"2020","unstructured":"Hatchett AA, Hughes B, Parr B. The influence cannabidiol on delayed onset of muscle soreness. Int J Phys Educ Sports Health. 2020;7:89\u201394.","journal-title":"Int J Phys Educ Sports Health"},{"issue":"1","key":"895_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/15502783.2024.2337252","volume":"21","author":"E Isenmann","year":"2024","unstructured":"Isenmann E, et al. Influence of short-term chronic oral cannabidiol application on muscle recovery and performance after an intensive training protocol - a randomized double-blind crossover study. J Int Soc Sports Nutr. 2024;21(1): 2337252.","journal-title":"J Int Soc Sports Nutr"},{"issue":"1","key":"895_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/15502783.2023.2280113","volume":"20","author":"EN Peters","year":"2023","unstructured":"Peters EN, et al. A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS). J Int Soc Sports Nutr. 2023;20(1): 2280113.","journal-title":"J Int Soc Sports Nutr"},{"issue":"3","key":"895_CR27","first-page":"1426","volume":"16","author":"A Alpy","year":"2023","unstructured":"Alpy A, et al. Topical cannabidiol and the progression rate of delayed onset muscle soreness. Int J Exerc Sci. 2023;16(3):1426\u201339.","journal-title":"Int J Exerc Sci"},{"key":"895_CR28","doi-asserted-by":"crossref","unstructured":"Pastina JT, et al. Topical cannabidiol application may not attenuate muscle soreness or improve performance: a randomized, double-blinded, placebo-controlled pilot study. Cannabis and Cannabinoid Research. 2024.","DOI":"10.1089\/can.2024.0012"},{"issue":"2","key":"895_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.70252\/VWUK7519","volume":"16","author":"WJ Stone","year":"2023","unstructured":"Stone WJ, et al. A pilot study on cannabidiol (CBD) and eccentric exercise: impact on inflammation, performance, and pain. Int J Exerc Sci. 2023;16(2):109\u201317.","journal-title":"Int J Exerc Sci"},{"issue":"1","key":"895_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40798-022-00417-y","volume":"8","author":"A Sahinovic","year":"2022","unstructured":"Sahinovic A, et al. Effects of cannabidiol on exercise physiology and bioenergetics: a randomised controlled pilot trial. Sports Med Open. 2022;8(1):27.","journal-title":"Sports Med Open"},{"issue":"3","key":"895_CR31","first-page":"388","volume":"9","author":"AM Lane","year":"2010","unstructured":"Lane AM, et al. Emotional intelligence and emotions associated with optimal and dysfunctional athletic performance. J Sports Sci Med. 2010;9(3):388\u201392.","journal-title":"J Sports Sci Med"},{"issue":"4","key":"895_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2478\/pjst-2018-0023","volume":"25","author":"A Same\u0142ko","year":"2018","unstructured":"Same\u0142ko A, Guszkowska M, Gala-Kwiatkowska A. Affective states influence sport performance in swimming. Pol J Sport Tourism. 2018;25(4):21\u20136.","journal-title":"Pol J Sport Tourism"},{"issue":"3","key":"895_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/104132001753144392","volume":"13","author":"D Perkins","year":"2001","unstructured":"Perkins D, Wilson GV, Kerr JH. The effects of elevated arousal and mood on maximal strength performance in athletes. J Appl Sport Psychol. 2001;13(3):239\u201359.","journal-title":"J Appl Sport Psychol"},{"issue":"1","key":"895_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4236\/psych.2015.61005","volume":"6","author":"D Jekauc","year":"2015","unstructured":"Jekauc D. Enjoyment during exercise mediates the effects of an intervention on exercise adherence. Psychology. 2015;6(1):48\u201354.","journal-title":"Psychology"},{"issue":"1","key":"895_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1479-5868-9-78","volume":"9","author":"PJ Teixeira","year":"2012","unstructured":"Teixeira PJ, et al. Exercise, physical activity, and self-determination theory: a systematic review. Int J Behav Nutr Phys Act. 2012;9(1):78.","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"4","key":"895_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/08870446.2015.1111372","volume":"31","author":"BA Lewis","year":"2016","unstructured":"Lewis BA, et al. Self-efficacy versus perceived enjoyment as predictors of physical activity behaviour. Psychol Health. 2016;31(4):456\u201369.","journal-title":"Psychol Health"},{"issue":"17","key":"895_CR37","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1113\/JP284205","volume":"602","author":"AM Jones","year":"2024","unstructured":"Jones AM. The fourth dimension: physiological resilience as an independent determinant of endurance exercise performance. J Physiol. 2024;602(17):4113\u201328.","journal-title":"J Physiol"},{"issue":"2","key":"895_CR38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/jappl.1991.70.2.683","volume":"70","author":"MJ Joyner","year":"1985","unstructured":"Joyner MJ. Modeling: optimal marathon performance on the basis of physiological factors. J Appl Physiol. 1985;70(2):683\u20137.","journal-title":"J Appl Physiol"},{"issue":"6","key":"895_CR39","first-page":"675","volume":"10","author":"B Balke","year":"1959","unstructured":"Balke B, Ware RW. An experimental study of physical fitness of Air Force personnel. US Armed Forces Med J. 1959;10(6):675\u201388.","journal-title":"US Armed Forces Med J"},{"issue":"2","key":"895_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1123\/ijsnem.20.2.145","volume":"20","author":"LE Armstrong","year":"2010","unstructured":"Armstrong LE, et al. Human hydration indices: acute and longitudinal reference values. Int J Sport Nutr Exerc Metab. 2010;20(2):145\u201353.","journal-title":"Int J Sport Nutr Exerc Metab"},{"issue":"5","key":"895_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034421","volume":"10","author":"A Suraev","year":"2020","unstructured":"Suraev A, et al. Cannabidiol (CBD) and \u03949-tetrahydrocannabinol (THC) for chronic insomnia disorder (\u2018CANSLEEP\u2019 trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial. BMJ Open. 2020;10(5): e034421.","journal-title":"BMJ Open"},{"issue":"2","key":"895_CR42","first-page":"88","volume":"29","author":"EF Coyle","year":"2001","unstructured":"Coyle EF, Gonz\u00e1lez-Alonso J. Cardiovascular drift during prolonged exercise: new perspectives. Exerc Sport Sci Rev. 2001;29(2):88\u201392.","journal-title":"Exerc Sport Sci Rev"},{"issue":"3","key":"895_CR43","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1123\/jsep.11.3.304","volume":"11","author":"CJ Hardy","year":"1989","unstructured":"Hardy CJ, Rejeski WJ. Not what, but how one feels: the measurement of affect during exercise. J Sport Exerc Psychol. 1989;11(3):304\u201317.","journal-title":"J Sport Exerc Psychol"},{"issue":"4","key":"895_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jshs.2017.09.010","volume":"9","author":"P Teques","year":"2020","unstructured":"Teques P, et al. Validation and adaptation of the physical activity enjoyment scale (PACES) in fitness group exercisers. J Sport Health Sci. 2020;9(4):352\u20137.","journal-title":"J Sport Health Sci"},{"key":"895_CR45","unstructured":"Borg G. Borg's perceived exertion and pain scales. Champaign, IL: Human Kinetics. viii, 104. 1998."},{"key":"895_CR46","doi-asserted-by":"publisher","DOI":"10.1123\/jsep.13.1.50","author":"D Kendzierski","year":"1991","unstructured":"Kendzierski D, DeCarlo KJ. Physical activity enjoyment scale: two validation studies. J Sport Exerc Psychol. 1991. https:\/\/doi.org\/10.1123\/jsep.13.1.50.","journal-title":"J Sport Exerc Psychol"},{"key":"895_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.2044-8260.1992.tb00997.x","volume":"31","author":"T Marteau","year":"1992","unstructured":"Marteau T, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992;31:301\u20136.","journal-title":"Br J Clin Psychol"},{"issue":"4","key":"895_CR48","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1152\/japplphysiol.00722.2009","volume":"107","author":"SJ Bailey","year":"2009","unstructured":"Bailey SJ, et al. Dietary nitrate supplementation reduces the O-2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol. 2009;107(4):1144\u201355.","journal-title":"J Appl Physiol"},{"issue":"3","key":"895_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1207\/s15327752jpa4703_14","volume":"47","author":"S Shacham","year":"1983","unstructured":"Shacham S. A shortened version of the profile of mood states. J Pers Assess. 1983;47(3):305\u20136.","journal-title":"J Pers Assess"},{"key":"895_CR50","doi-asserted-by":"crossref","unstructured":"Kevin RC, et al. A validated method for the simultaneous quantification of CBD, THC, and their metabolites in human plasma, and application to plasma samples from an oral CBD open label trial. Drug Test Anal. 2020.","DOI":"10.1002\/dta.2947"},{"issue":"1","key":"895_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00005768-199701000-00022","volume":"29","author":"SE Griffin","year":"1997","unstructured":"Griffin SE, Robergs RA, Heyward VH. Blood pressure measurement during exercise: a review. Med Sci Sports Exerc. 1997;29(1):149\u201359.","journal-title":"Med Sci Sports Exerc"},{"key":"895_CR52","unstructured":"Core Team R. R: A language and environment for statistical computing. Foundation for Statistical Computing, Vienna, Austria. 2013."},{"key":"895_CR53","first-page":"1","volume":"67","author":"D Bates","year":"2014","unstructured":"Bates D, et al. Fitting linear mixed-effects models using the lme4 package in R. J Stat Softw. 2014;67:1\u201348.","journal-title":"J Stat Softw"},{"key":"895_CR54","doi-asserted-by":"crossref","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest package: tests in linear mixed effects models. J Stat Softw. 2017;82(13).","DOI":"10.18637\/jss.v082.i13"},{"key":"895_CR55","unstructured":"Christensen R. ordinal\u2014Regression Models for Ordinal Data. R package version 2023.12-4.1. 2023."},{"key":"895_CR56","unstructured":"Herve M. RVAideMemoire: testing and plotting procedures for biostatistics. R package version 0.9-83-2, 2023. 2023."},{"key":"895_CR57","unstructured":"Lenth R. emmeans: Estimated marginal means, aka least-squares means. R package version 1.7.4-1, 2022. 2022."},{"key":"895_CR58","unstructured":"Fox JW. An {R} Companion to applied regression. 3rd edn. 2019. Thousand Oaks CA: Sage."},{"key":"895_CR59","unstructured":"Barto\u0144 K. MuMIn: multi-model inference. R package version 1.46.0, 2022."},{"key":"895_CR60","volume-title":"Data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. Data analysis. New York: Springer; 2016."},{"issue":"1","key":"895_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/can.2015.0012","volume":"1","author":"I Ujv\u00e1ry","year":"2016","unstructured":"Ujv\u00e1ry I, Hanu\u0161 L. Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy. Cannabis Cannabinoid Res. 2016;1(1):90\u2013101.","journal-title":"Cannabis Cannabinoid Res"},{"key":"895_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101462","author":"J Matheson","year":"2022","unstructured":"Matheson J, Bourgault Z, Le Foll B. Sex differences in the neuropsychiatric effects and pharmacokinetics of cannabidiol: a scoping review. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12101462.","journal-title":"Biomolecules"},{"issue":"11","key":"895_CR63","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","volume":"32","author":"L Taylor","year":"2018","unstructured":"Taylor L, et al. A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects. CNS Drugs. 2018;32(11):1053\u201367.","journal-title":"CNS Drugs"},{"issue":"4","key":"895_CR64","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s40279-023-01980-4","volume":"54","author":"LP Gibson","year":"2024","unstructured":"Gibson LP, et al. Acute effects of ad libitum use of commercially available cannabis products on the subjective experience of aerobic exercise: a crossover study. Sports Med. 2024;54(4):1051\u201366.","journal-title":"Sports Med"},{"issue":"1","key":"895_CR65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40798-024-00727-3","volume":"10","author":"D McCartney","year":"2024","unstructured":"McCartney D, et al. The effect of cannabidiol on subjective responses to endurance exercise: a randomised controlled trial. Sports Medicine - Open. 2024;10(1):61.","journal-title":"Sports Medicine - Open"},{"issue":"1","key":"895_CR66","doi-asserted-by":"publisher","first-page":"21744","DOI":"10.1038\/s41598-021-01128-2","volume":"11","author":"ML Drennan","year":"2021","unstructured":"Drennan ML, et al. Acute objective and subjective intoxication effects of legal-market high potency THC-dominant versus CBD-dominant cannabis concentrates. Sci Rep. 2021;11(1):21744.","journal-title":"Sci Rep"},{"issue":"9","key":"895_CR67","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s00213-019-05246-8","volume":"236","author":"TR Arkell","year":"2019","unstructured":"Arkell TR, et al. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Psychopharmacology. 2019;236(9):2713\u201324.","journal-title":"Psychopharmacology"},{"issue":"7","key":"895_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220025","volume":"14","author":"H Chung","year":"2019","unstructured":"Chung H, Fierro A, Pessoa-Mahana CD. Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: an in silico study. PLoS ONE. 2019;14(7): e0220025.","journal-title":"PLoS ONE"},{"issue":"7","key":"895_CR69","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/ejsc.12116","volume":"24","author":"SH Gillham","year":"2024","unstructured":"Gillham SH, et al. Does a broad-spectrum cannabidiol supplement improve performance in a 10-min cycle ergometer performance-test? Eur J Sport Sci. 2024;24(7):870\u20137.","journal-title":"Eur J Sport Sci"},{"issue":"3","key":"895_CR70","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1152\/japplphysiol.00757.2023","volume":"136","author":"CP Cheung","year":"2024","unstructured":"Cheung CP, et al. Cannabis containing THC impairs 20-min cycling time trial performance irrespective of the method of inhalation. J Appl Physiol (1985). 2024;136(3):583\u201391.","journal-title":"J Appl Physiol (1985)"},{"key":"895_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/nu15122664","author":"VA Flores","year":"2023","unstructured":"Flores VA, et al. Effects of oral cannabidiol on health and fitness in healthy adults: an 8-week randomized trial. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15122664.","journal-title":"Nutrients"},{"key":"895_CR72","doi-asserted-by":"publisher","DOI":"10.1113\/JP280221","author":"LM Burke","year":"2020","unstructured":"Burke LM, et al. Adaptation to a low carbohydrate high fat diet is rapid but impairs endurance exercise metabolism and performance despite enhanced glycogen availability. J Physiol. 2020. https:\/\/doi.org\/10.1113\/JP280221.","journal-title":"J Physiol"},{"issue":"2","key":"895_CR73","first-page":"628","volume":"55","author":"KN Frayn","year":"1983","unstructured":"Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol. 1983;55(2):628\u201334.","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"key":"895_CR74","doi-asserted-by":"crossref","unstructured":"Emhoff CW, Messonnier LA. Concepts of lactate metabolic clearance rate and lactate clamp for metabolic inquiry: a mini-review. Nutrients. 2023;15(14).","DOI":"10.3390\/nu15143213"},{"issue":"1","key":"895_CR75","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mce.2006.12.038","volume":"267","author":"P Cavuoto","year":"2007","unstructured":"Cavuoto P, et al. Effects of cannabinoid receptors on skeletal muscle oxidative pathways. Mol Cell Endocrinol. 2007;267(1):63\u20139.","journal-title":"Mol Cell Endocrinol"},{"key":"895_CR76","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-2895-8_5","volume":"872","author":"T Kuo","year":"2015","unstructured":"Kuo T, et al. Regulation of glucose homeostasis by glucocorticoids. Adv Exp Med Biol. 2015;872:99\u2013126.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"895_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00421-003-0957-5","volume":"91","author":"S Vincent","year":"2004","unstructured":"Vincent S, et al. Plasma glucose, insulin and catecholamine responses to a Wingate test in physically active women and men. Eur J Appl Physiol. 2004;91(1):15\u201321.","journal-title":"Eur J Appl Physiol"},{"issue":"2","key":"895_CR78","first-page":"213","volume":"26","author":"AW Zuardi","year":"1993","unstructured":"Zuardi AW, Guimar\u00e3es FS, Moreira AC. Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers. Braz J Med Biol Res. 1993;26(2):213\u20137.","journal-title":"Braz J Med Biol Res"},{"key":"895_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbii.2024.100079","volume":"7","author":"R Townsend","year":"2024","unstructured":"Townsend R, et al. Low dose daily CBD beverage consumption for eight weeks does not improve physical and mental health measures in healthy individuals: a randomized clinical trial. Brain Behav Immunity Integrat. 2024;7: 100079.","journal-title":"Brain Behav Immunity Integrat"},{"issue":"2","key":"895_CR80","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/can.2019.0078","volume":"7","author":"JP Liebling","year":"2022","unstructured":"Liebling JP, et al. An analysis of over-the-counter cannabidiol products in the United Kingdom. Cannabis Cannabinoid Res. 2022;7(2):207\u201313.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"5","key":"895_CR81","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/19390211.2020.1766634","volume":"17","author":"BJ Gurley","year":"2020","unstructured":"Gurley BJ, et al. Content versus label claims in cannabidiol (CBD)-containing products obtained from commercial outlets in the state of Mississippi. J Diet Suppl. 2020;17(5):599\u2013607.","journal-title":"J Diet Suppl"},{"key":"895_CR82","unstructured":"World Anti Doping Agency. World Anti Doping Code 2021. 2021. Available from: https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2021_wada_code.pdf."},{"issue":"2","key":"895_CR83","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00204-024-03904-1","volume":"99","author":"E Isenmann","year":"2025","unstructured":"Isenmann E, et al. Short-term repeated oral intake of low dose cannabidiol: effects on liver enzyme activity and creatinine concentration during intense exercise. Arch Toxicol. 2025;99(2):815\u201324.","journal-title":"Arch Toxicol"},{"issue":"4","key":"895_CR84","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10286-022-00878-x","volume":"32","author":"K \u00d6zg\u00fcnen","year":"2022","unstructured":"\u00d6zg\u00fcnen K, et al. The relationship between cardiac damage biomarkers and heart rate variability following 60 min of running. Clin Auton Res. 2022;32(4):249\u201360.","journal-title":"Clin Auton Res"},{"issue":"11","key":"895_CR85","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1589\/jpts.27.3387","volume":"27","author":"Y Bakar","year":"2015","unstructured":"Bakar Y, et al. Effect of manual lymph drainage on removal of blood lactate after submaximal exercise. J Phys Ther Sci. 2015;27(11):3387\u201391.","journal-title":"J Phys Ther Sci"},{"key":"895_CR86","doi-asserted-by":"crossref","unstructured":"Ribeiro FM, et al. Is there an exercise-intensity threshold capable of avoiding the leaky gut? Front Nutr. 2021;8.","DOI":"10.3389\/fnut.2021.627289"},{"issue":"2","key":"895_CR87","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/23328940.2016.1179380","volume":"3","author":"N Vargas","year":"2016","unstructured":"Vargas N, Marino F. Heat stress, gastrointestinal permeability and interleukin-6 signaling - implications for exercise performance and fatigue. Temperature (Austin). 2016;3(2):240\u201351.","journal-title":"Temperature (Austin)"},{"issue":"5","key":"895_CR88","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1123\/ijspp.2019-0973","volume":"16","author":"AM Wallett","year":"2021","unstructured":"Wallett AM, et al. Running at increasing intensities in the heat induces transient gut perturbations. Int J Sports Physiol Perform. 2021;16(5):704\u201310.","journal-title":"Int J Sports Physiol Perform"},{"key":"895_CR89","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","volume":"14","author":"SC Bischoff","year":"2014","unstructured":"Bischoff SC, et al. Intestinal permeability\u2013a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189.","journal-title":"BMC Gastroenterol"},{"key":"895_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122598","author":"JDR Souza","year":"2022","unstructured":"Souza JDR, et al. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020\u20132022). Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14122598.","journal-title":"Pharmaceutics"},{"issue":"6","key":"895_CR91","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/17425255.2020.1754793","volume":"16","author":"RG Dos Santos","year":"2020","unstructured":"Dos Santos RG, et al. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials. Expert Opin Drug Metab Toxicol. 2020;16(6):517\u201326.","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Sports Medicine - Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40798-025-00895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40798-025-00895-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40798-025-00895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:03:03Z","timestamp":1771866183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40798-025-00895-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["895"],"URL":"https:\/\/doi.org\/10.1186\/s40798-025-00895-w","relation":{},"ISSN":["2198-9761"],"issn-type":[{"value":"2198-9761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated to amend some figure citations and placements.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Sydney Local Health District\u2019s Human Research Ethics Committee (2021\/ ETH11945; X21-0392), registered prospectively with the Australia and New Zealand Clinical Trials Registry (ACTRN12622000717752) on 19th May, 2022 and conducted in accordance with the standards of ethics outlined in the Declaration of Helsinki. All participants provided written informed consent prior to enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"A.S., R.G., K.W., I.S.M., and D.M. receive salary support from the Lambert Initiative for Cannabinoid Therapeutics. I.S.M. and D.M. has received consulting fees from Medicinal Cannabis Industry Australia (MCIA). I.S.M. has also received consulting fees Kinoxis Therapeutics and Janssen. I.S.M. and D.M. have served as expert witnesses in medicolegal cases involving cannabis and cannabinoids. I.S.M is also named as an inventor on several patents relating to novel cannabinoid therapeutics (PCT\/AU2018\/05089 and PCT\/AU2019\/050554).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}